Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00763295 · ClinicalTrials.gov registry record
Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis in Patients With HIV?
A clinical trial, sponsored by Northwell Health.
- Completed
- Registry status
- 53
- Enrollment target
NCT00763295: Completed study, sponsored by Northwell Health.
NCT00763295 is a clinical trial that has completed, run by Northwell Health. The registered enrollment target is 53 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00763295 has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- 53 participants
- Enrollment target
Study Summary
HIV infection highly increases the risk of progression of latent tuberculosis (TB) to active disease that therapy is recommended for all PPD-positive, HIV-infected patients, regardless of age. Sensitivity of the PPD testing is, however, dependent on a normal T cell function. Therefore, an accurate and reliable method for detection of latent tuberculosis in patients with HIV is urgently needed. This prospective study will examine the utility of interferon-gamma (IFN-γ) based assay, T-SPOT.TB,for detection of TB in HIV-infected individuals.
Interventions
- OTHER T-Spot.TB test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2008-05 |
| Est. Completion | 2010-01 |
What the finished NCT00763295 record still lists
NCT00763295 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 53 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which T-Spot.TB test is the first listed.
NCT00763295 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00763295 about?
NCT00763295 is a clinical study titled "Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis in Patients With HIV?". HIV infection highly increases the risk of progression of latent tuberculosis (TB) to active disease that therapy is recommended for all PPD-positive, HIV-infected patients, regardless of age. Sensitivity of the PPD testing is, however, dependent on a normal T cell function. Therefore, an accurate ...
What is the current status of trial NCT00763295?
This trial is currently completed. The enrollment target is 53 participants. The study started on 2008-05. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00763295?
The interventions under investigation include: T-Spot.TB test (OTHER).
Who is sponsoring clinical trial NCT00763295?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia